Iceland· IS-EU/1/23/1790/001-003
Velsipity
A etrasimod product containing etrasimod arginine, registered in Iceland by Pfizer Europe MA EEIG*. The same ATC class is registered in 13 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Etrasimod is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AE05 (etrasimod), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 8 of them publish a price we can compare per daily dose
Etrasimod · ATC L04AE05
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of etrasimod costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Etrasimod · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$35.97
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Etrasimod arginine
- Manufacturer
- Pfizer Europe MA EEIG*
- Country
- Iceland (IS)
- ATC code
- L04AE05
- ATC class
- Etrasimod
- Defined daily dose
- 2 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean08441028 stk x1 þpakkiISK 124336
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Etrasimod in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVELSIPITYPfizer Europe MA EEIG, Bruxelles
- FinlandVelsipityPfizer Europe MA EEIG
- BelgiumVelsipity 2 mgPfizer Europe MA
- IrelandVelsipity 2 mg film-coated tabletsPfizer Europe MA EEIG
- NetherlandsVelsipity 2 mg filmomhulde tabletPfizer Europe MA EEIG
- United StatesVelsipityPfizer Laboratories Div Pfizer Inc
- FranceVELSIPITY 2 mg, comprimé pelliculéPFIZER EUROPE MA EEIG (BELGIQUE)
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de583705-c877-44c0-92c8-09404c35ea94 GET /v1/drugs/de583705-c877-44c0-92c8-09404c35ea94?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L04AE05",
"marketed": true,
"strength": "2 mg",
"ma_number": "EU/1/23/1790/001-003",
"substance": "Etrasimod arginine",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í meltingarlækningum og ónæmisfræði.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45338"
}See everything about etrasimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.